Skip to content

CARDIFF ONCOLOGY, INC.

CRDF

CIK 0001213037

← back to feed
Revenue (TTM)
$391K
−13.2% YoY Q1 Apr 2026
Net Income (TTM)
−$50.98M
−0.9% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.76
+27.4% YoY Q1 Apr 2026
Gross Margin
93.2%
Q1 Apr 2026
Operating Margin
-13,806.4%
Q1 Apr 2026
Net Margin
-13,038.4%
Q1 Apr 2026
Free Cash Flow (TTM)
−$41.74M
Q1 Apr 2026
Cash
$8.54M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
68.37M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings